← SynDRA
BRD-K79437791
SynDRA canonical compound SYN0062564 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PPARG |
|---|
| Mechanism of action | methyltransferase inhibitor |
|---|
| Indication | acne vulgaris (AV) |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
- methyltransferase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- KAT2A
- MAPT
- TDP1
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- RAPGEF3
- RAPGEF4
- RPGF3
- RPGF4
Cross-references
Synonyms
- acetyl-farnesyl-cysteine
- CBiol_001762
- CBiol_001929
- KBioGR_000104
- KBioGR_000217
- KBioSS_000104
- KBioSS_000217
- SCHEMBL664393
- KBio2_000104
- KBio2_000217
- KBio2_002672
- KBio2_002785
- KBio2_005240
- KBio2_005353
- KBio3_000207
- KBio3_000208
- KBio3_000433
- KBio3_000434
- XTURYZYJYQRJDO-IBGZPJMESA-N
- Bio1_000048
- Bio1_000215
- Bio1_000537
- Bio1_000704
- Bio1_001026
- Bio1_001193
- Bio2_000104
- Bio2_000217
- Bio2_000584
- Bio2_000697
- AKOS030241080
- NS00126738
- (2R)-2-acetamido-3-(3,7,11-trimethyldodeca-2,6,10-trienylthio)propanoic acid
Look up BRD-K79437791 in the interactive SynDRA portal →